Background: Lead dislodgement (LD) is a well-recognized complication during implantation of cardiac implantable electronic devices (CIEDs). An intraprocedural protocol, referred to as reduction of LD protocol, was developed to reduce the risk of LD.
The current study was designed to retrospectively assess the incidence of LD in a large tertiary care hospital; then, to develop a protocol and prospectively measure the impact of the new protocol upon LD events.
METHODS

Reduction of LD (RLD) protocol
A consensus of the electrophysiology faculty was reached to implement a prospective strategy (RLD Protocol) that included each of the following:
1. Insertion of a straight stylet down the right atrium (RA) lead and applying forward pressure while monitoring for LD on fluoroscopy ( Figure 1 ). With this technique, a straight stylet is advanced to just proximal to the beginning of the "U"-shaped loop in the lead. The lead and stylet are then advanced together about 1 cm. With this maneuver, the intent is not to try to dislodge the lead, but rather to screen for a lead that is not actively fixated into the appendage tissue. In case of noncapture at the minimum laboratory threshold, the lead was adjusted and the maneuvers repeated.
4.
Testing of sensitivity at least 10 minutes after each lead placement, oftentimes just before placement of the lead into the device header, to assess for reduction in sensed R or P waves below laboratory standard. State University approved the study.
Patient population
There were two study populations: (1) Table 1 details the baseline characteristics in the control and intervention group. Average age of the patients was 67 ± 14.1 years in the control group and 66 ± 14.5 years in the intervention group. Most common comorbidity was heart failure followed by diabetes mellitus and myocardial infarction. Almost half of the patients had history of atrial fibrillation or atrial flutter. Average left ventricular ejection fraction was 42% in both groups. All RA and RV leads were active fixation leads. ICD leads were the most common leads implanted. Number of quadripolar CS leads was lower in the control group (n = 100; 15%) compared to the intervention group (n = 225; 63%). Overall, both the control and intervention groups were comparable for the clinical characteristics and the type of implanted leads.
CIED implant technique
The device was implanted via the left or right axillary vein (as indicated) by a staff electrophysiologist according to the standard protocol. Access was achieved using the modified Seldinger technique followed by the implantation of the leads in a standard fashion. Once the physician was satisfied with the position of the leads and the measured lead parameters, the RLD protocol was performed on each lead. If a predefined intraprocedural criterion for inadequate lead implantation was fulfilled, the lead revision was performed. The RLD protocol was repeated until each lead was confirmed by the protocol to be in proper position.
Postprocedure care and follow-up
A chest x-ray was performed approximately 4 hours after lead implantation to assess for LD. Patients were monitored overnight in the hospital followed by device interrogation for the assessment of sensing and pacing thresholds the following day. The device was then interrogated at 7-10 days after the procedure during routine evaluation of the incision. In case of declining sensing and pacing parameters, a closer follow-up was scheduled; otherwise, every patient received a third evaluation of the leads at 30 days postimplant. Provocative maneuvers such as assessing capture threshold during deep breathing and coughing were not performed at follow-up.
Primary outcome
The primary outcome was number of leads requiring reoperation for lead revision in the first 30 days after implantation. These revisions were prompted by (1) 
Statistical analysis
Categorical data are represented by percentages and continuous data are represented as means and standard deviation. The baseline characteristics consisted of normally distributed variables and were analyzed using the t-test or 2 test as appropriate. The number of LD in
TA B L E 2 The impact of RLD protocol on lead dislodgement during 30-day follow-up
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RESULTS
Implementation of lead reduction protocol
A total of 4,294 leads were implanted in the control group over a period of 27 months, while 2,361 were implanted in the intervention group over a period of 17 months. Total LD occurrences were 44 (1.02%) before and 10 (0.4%) after implementation of the protocol. The protocol significantly reduced the incidence of LD during 30 days postprocedure (P = 0.014) ( Table 2 ). The majority of the LD events occurred in the first 24 hours after the procedure (42 in the control group and seven in the intervention group), while the rest (two in the control group and three in the intervention group) were identified after discharge in the first 30 days after implant. The most common reason for lead revision was fluoroscopic displacement (Table 3) .
Predictors of LD
A comparison of patients with and without LD showed similar prevalence of baseline demographic and clinical characteristics (Table 4) . A multivariable logistical regression analysis performed to assess the risk factors for LD did not show any predictive parameters (Table 5) . Note: AF/AFL = atrial fibrillation/flutter; BMI = body mass index; BUN = blood urea nitrogen; DM = diabetes mellitus; LD = lead dislodgement; LVEF = left ventricular ejection fraction; MI = myocardial infarction. Values are given in mean ± standard deviation for continuous variables and % for categorical variables. Note: AF/AFL = atrial fibrillation/flutter; CI = confidence interval; LD = lead dislodgement; LVEF = left ventricular ejection fraction; OR = odds ratio. Values are given in mean ± standard deviation for continuous variables and % for categorical variables.
TA B L E 4 Comparison of patients with versus without lead dislodgement
TA B L E 5
DISCUSSION
Main findings
The main finding of this study is that with a concerted effort by electrophysiologists and laboratory staff, a specific protocol was developed and successfully able to reduce the risk of LD by about 60%
(1.02-0.4%). This protocol consists of a few simple components and, with the addition of less than 2 minutes of additional work, the benefits of the protocol are significant.
Continuous process improvement
This process reflects the importance of continuous process improvement. Prior to the LD protocol, the dislodgement rate was 1.02%, consistent with other published studies. 3, 5, 6 Nonetheless, when considering the high volume of transvenous leads implanted, 1.02%
represents a large number of patients, especially when considering the risks associated with repeat invasive procedure for lead revision, such as infection. The collection and analysis of baseline data, and subsequent development of a consensus to implement a new protocol followed by assessment of its efficacy, is a process that could be applied to other seemingly low-incidence complications in various electrophysiological procedures. 7
Predictors of LD
Both the control and intervention groups had similar baseline characteristics including age; gender; height; weight; and comorbidities such as heart failure, atrial fibrillation, and history of myocardial infarction.
The distribution of RA, RV, and CS leads was similar between the control and intervention groups and there was a similar reduction of LD for all lead types. Additionally, there was minimal change in the baseline characteristics between individuals who did and did not experience LD. By multivariable regression analysis, there was no predictor for increased LD. This is in contrast to previous studies where certain clinical features were found to predict the risk of LD. For example, a meta-analysis of the CTOPP, DANISH, and UKPACE trials showed an association with LD and age > 75 years. 8 Another retrospective study showed obese females (BMI ≥ 30) had a higher incidence of LD than both obese males and also men and women with BMI < 30. 9 An additional retrospective analysis associated LD with individuals who presented with specific comorbidities, including a worse heart failure status and AF and AFL. 3 Similar to previous studies, there was a trend toward decreased risk of lead revisions with the use of quadripolar leads; however, this did not result in statistical significance. [10] [11] [12] 
Study limitations
This is a single-center study; however, the large sample size undergoing the procedure in a clinically indicated manner is unlikely to bias the LD rate, and reflects that this protocol can be implemented into other clinical practices without significant change in workflow. Additionally, the idea that low incidence of a complication can further be lowered by a continuous process improvement is applicable universally. Another limitation of the study is that the data for adjustment attempts needed due to LD protocol were not recorded. The study looked at achieving intraprocedural endpoints for each lead and the compliance with the protocol was > 90%.
Conclusion
Intraprocedural maneuvers performed systematically to assess the adequacy of lead implantation results in reduced risk of LD. Use of such continuous process improvement techniques may be able to further mitigate the risk of complications from CIED implantation.
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